<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mig01/PMC7231774/results/search/migration/results.xml">
  <result pre="and effect of BTK inhibitor on prostate cancer cell proliferation," exact="migration" post="and invasion. Methods BTK expression was assessed by immunohistochemistry;"/>
  <result pre="migration and invasion. Methods BTK expression was assessed by immunohistochemistry;" exact="migration" post="and invasion prostate cancer cell lines (DU145 and PC3)"/>
  <result pre="cancer cell lines (DU145 and PC3) were assessed by Transwell" exact="migration" post="and wound﻿-healing assay; cancer cell proliferation was assessed using"/>
  <result pre="with bone metastasis. BTK inhibitor (Ibrutinib) significantly inhibited cell proliferation," exact="migration" post="and invasion of prostate cancer cells as well as"/>
  <result pre="significantly block the inhibitory effect of Ibrutinib on cell proliferation," exact="migration" post="and invasion, and protein synthesis of MMP-2 and MMP-9"/>
  <result pre="suppression of BTK with Ibrutinib resulted in inhibition of proliferation," exact="migration" post="and invasion of the cells. In addition, MMP-2 and"/>
  <result pre="Invasion of Prostate Cancer Cells Next effect of Ibrutinib on" exact="migration" post="and invasion of prostate cancer cell lines, DU145 and"/>
  <result pre="assay results, 5 and 10µM Ibrutinib significantly inhibited not only" exact="migration" post="of DU145 cells (top row of Figure 4A and"/>
  <result pre="P &amp;lt; 0.05). Similar effect of Ibrutinib on PC3 cell" exact="migration" post="and invasion was found (Figure 4C and D, P"/>
  <result pre="&amp;lt; 0.01; ***P &amp;lt; 0.001. Figure 4 Effect Ibrutinib on" exact="migration" post="and invasion of prostate cancer cells. Cell migration and"/>
  <result pre="Ibrutinib on migration and invasion of prostate cancer cells. Cell" exact="migration" post="and invasion were assessed using Transwell assay as described"/>
  <result pre="as described in the methods. (A) Effect of Ibrutinib on" exact="migration" post="(top row) and invasion (bottom row) in DU145 cells."/>
  <result pre="(B) Quantification of the Ibrutinib inhibitory effect on DU145 cell" exact="migration" post="(left) and invasion (right). Vertical axes: migrated or invaded"/>
  <result pre="&amp;lt; 0.01; ***P &amp;lt; 0.001. (C) Effect of Ibrutinib on" exact="migration" post="(top row) and invasion (bottom row) in PC3 cells."/>
  <result pre="(D) Quantification of the Ibrutinib inhibitory effect on PC3 cell" exact="migration" post="(left) and invasion (right). Vertical axes: migrated or invaded"/>
  <result pre="investigate potential mechanism of Ibrutinib inhibition on prostate cancer cell" exact="migration" post="and invasion, effect of Ibrutinib on the protein synthesis"/>
  <result pre="further investigate role of BTK in modulating prostate cancer cell" exact="migration" post="and invasion, plasmid of negative control or overexpressing BTK"/>
  <result pre="then pre-treated with 5µM Ibrutinib for 24 h followed by" exact="migration" post="and invasion using Transwell assay method. As shown in"/>
  <result pre="invasion using Transwell assay method. As shown in Figure 6," exact="migration" post="(Figure 6A) and invasion (Figure 6B) capability of the"/>
  <result pre="but significantly blocked the inhibitory effect of Ibrutinib on cell" exact="migration" post="and invasion (P &amp;lt; 0.05). Similar effect was observed"/>
  <result pre="0.05). Figure 6 Effect of BTK overexpressing on the cell" exact="migration" post="and invasion. Plasmid containing negative control (NC) or overexpressing"/>
  <result pre="methods. Cells were then treated with 5µM Ibrutinib followed by" exact="migration" post="and invasion assay as described in the methods. (A"/>
  <result pre="inhibitor, Ibrutinib, significantly inhibited prostate cancer cell proliferation, wound healing," exact="migration" post="and invasion of the prostate cancer cells; and inhibited"/>
  <result pre="cancer cells partially antagonized the inhibitory effect of Ibrutinib on" exact="migration" post="and invasion of the prostate cancer cells as well"/>
  <result pre="related signaling play an important role in the cellular proliferation," exact="migration" post="and invasion of prostate cancer. Tyrosine-protein kinases induce protein"/>
  <result pre="cellular behaviors, including cell proliferation and differentiation, survival and death," exact="migration" post="and invasion, and neoplastic formation.14,15 In this content, Bruton’s"/>
  <result pre="cancers with bone metastasis. Furthermore, Ibrutinib significantly inhibited cellular proliferation," exact="migration" post="and invasion of prostate cancer. Findings of the current"/>
  <result pre="that showed BTK signal transduction was critical for proliferation and" exact="migration" post="of prostate cancer cells and suggested that BTK could"/>
  <result pre="connective tissues as well as transfer to distant organs.24,25 Cell" exact="migration" post="and invasion require proteolytic action of the enzymes that"/>
  <result pre="of the extracellular matrix (ECM) so that cancer cells initiate" exact="migration" post="and disseminate into the surrounding tissues. In this regard,"/>
  <result pre="and regulating functions of various kinds of cancer cells including" exact="migration" post="and angiogenesis, and thus, MMPs have been the targets"/>
  <result pre="the prostate cancer with bone metastasis. Ibrutinib significantly inhibited proliferation," exact="migration" post="and invasion of the prostate cancer cells as well"/>
 </snippets>
</snippetsTree>
